# SODIUM BICARBONATE
> **ANDA211091** · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2019-06-20
## Drug
- **FDA Application Number:** ANDA211091
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM BICARBONATE
- **Generic name:** SODIUM BICARBONATE
- **Active ingredients:** SODIUM BICARBONATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EXELA PHARMA
- **Manufacturer:** Civica
- **First approval:** 2019-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211091)
---
*AI Analytics · CC0 1.0*